carotid artery stenting device for narrowing of arteries
Protocol: STUDY00004781
Full Title
Protection against Emboli during caRotid artery stenting using a 3-in-1 delivery system comprised oF a pOst-dilation balloon, integRated eMbolic filter, and A Novel Carotid stEnt II
Description
This study enrolls adults who have been chosen to participate because they have carotid narrowing (a blockage) that may benefit from the use of the Neuroguard IEP System, a carotid stent and filter used during a medical procedure to open the blockage.

We expect that your participation in this research study will last about 3 years. After your carotid stenting procedure, you will have follow-up visits at 1 month, 6 months, 1 year or 12 months, 2 years or 24 months and 3 years or 36 months. Study takes place at Buffalo General Medical Center/Gates Vascular Institute.

Technical Description

To evaluate the safety and effectiveness of the Neuroguard IEP System in subjects for the treatment of carotid artery stenosis at elevated risk for adverse events following carotid endarterectomy
Compensation: No
Eligibility
-Adults ages 20-80.
-Have been diagnosed with carotid artery stenosis treatable with carotid artery stenting.
-Additional eligibility criteria apply.
Age Group: Adults
Principal Investigator: ELAD LEVY
ClinicalTrials.gov: Open Study
Contact(s)
JENNIFER GAY
jgay@ubns.com
+1 716-888-4811
Want to Learn More?
Enrollment Update

Due to COVID-19, new enrollment in research studies will be greatly limited. If you are interested in a study, there may be a longer waiting period to receive a response to your inquiry. View the guidance for research participants for additional information.

Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.